ACE2-IgG4-Fc fusion protein neutralizes SARS-CoV-2, including several variants, at pM concentration Dec. 17, 2021
Nucleoside analogue sangivamycin shows in vitro activity against several variants of SARS-CoV-2 Dec. 16, 2021
In vitro data show reduction in neutralizing activity of ADG-20 against SARS-CoV-2 Omicron variant Dec. 15, 2021
TYME-19 demonstrates antiviral effect against SARS-CoV-2 in human lung epithelial cells Dec. 14, 2021
RSS